Follow-The-Filings

Security · featured owners

OSCR Oscar Health Inc.

Health Care CL A Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 4.8%
  • $182M
  • 1 new 2 exits

OSCR (Oscar Health Inc.) is held in 2 featured 13F books as of 2026 Q2. Josh Kushner - Thrive Capital Management is the largest tracked holder by portfolio weight (4.8%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 4.8% (Josh Kushner - Thrive Capital Management) · not free-float ownership

  1. Josh Kushner 4.8%
  2. Polen Capital Management new 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Josh Kushner - Thrive Capital Management 2026 Q2 4.8% Hold 6,343,617 $181M history
Polen Capital Management 2026 Q2 0.01% New 0.01% 38,701 $1M history
Marc Stad - Dragoneer Investment Group exited 2026 Q2 last 2026 Q1 0.14% Exit −0.14% 365,573 $4M history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 11,000 $126K history

2 current · 2 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01 Filing Doc
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 18, 2026 Filing Doc
4 Period Sep 18, 2026 · 2 forms Filing Doc
4 Period Sep 3, 2026 · 5 forms Filing Doc
4 Period Aug 27, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Jul 9, 2026 · 3 forms Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 29, 2026 Filing Doc
4 Period Jun 25, 2026 Filing Doc
4 Period Jun 23, 2026 Filing Doc
4 Period Jun 4, 2026 · 5 forms Filing Doc
4 Period Jun 2, 2026 · 3 forms Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $15.44M $20.58M $28.59M
Net income -$270.73M $25.43M -$443.15M
Net margin * -1753.2% 123.6% -1549.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.06B $2.85B $4.61B
Total non-current assets * $0.54B $2B $1.71B
Total assets $3.6B $4.84B $6.33B
Total current liabilities $2.43B $3.46B $4.86B
Total non-current liabilities * $366.35M $360.84M $482.09M
Total equity $0.804B $1.01B $0.978B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$0.272B $0.978B $1.09B
Cash from investing $0.577B -$1.39B -$0.241B
Cash from financing $6.45M $68.39M $399.21M
Net change in cash $0.311B -$0.341B $1.25B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders